Genetic mutual relationship between PTEN and p53 in gastric cancer

Cancer Letters

Volumn 227, Issue 1, 2005, Pages 33-38

  Oki, Eiji ^a   Tokunaga, Eriko ^a   Nakamura, Toshihiko ^a   Ueda, Naoyuki ^a   Futatsugi, Motonori ^a   Mashino, Kohjiro ^a   Yamamoto, Manabu ^a   Watanabe, Masayuki ^a   Ikebe, Masahiko ^a   Kakeji, Yoshihiro ^b   Baba, Hideo ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Gastric cancer; Loss of heterozygosity; p53; PTEN

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ALLELE; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; GENE FREQUENCY; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

EID: 22744452500     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.006     Document Type: Article

References (25)

1. P.A. Steck, M.A. Pershouse, S.A. Jasser, W.K. Yung, H. Lin, and A.H. Ligon Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Nat. Genet. 15 1997 356 362
2. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
3. H. Tashiro, M.S. Blazes, R. Wu, K.R. Cho, S. Bose, and S.I. Wang Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies Cancer Res. 57 1997 3935 3940
4. P. Guldberg, P. Thor Straten, A. Birck, V. Ahrenkiel, A.F. Kirkin, and J. Zeuthen Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma Cancer Res. 57 1997 3660 3663
5. Y.E. Whang, X. Wu, H. Suzuki, R.E. Reiter, C. Tran, and R.L. Vessella Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression Proc. Natl Acad. Sci. USA 95 1998 5246 5250
6. S.I. Wang, J. Puc, J. Li, J.N. Bruce, P. Cairns, D. Sidransky, and R. Parsons Somatic mutations of PTEN in glioblastoma multiforme Cancer Res. 57 1997 4183 4186
7. D.H. Teng, R. Hu, H. Lin, T. Davis, D. Iliev, and C. Frye MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines Cancer Res. 57 1997 5221 5225
8. G.L. Maxwell, J.I. Risinger, C. Gumbs, H. Shaw, R.C. Bentley, and J.C. Barrett Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Cancer Res. 58 1998 2500 2503
9. P.L. Dahia, D.J. Marsh, Z. Zheng, J. Zedenius, P. Komminoth, and T. Frisk Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors Cancer Res. 57 1997 4710 4713
10. T. Maehama, and J.E. Dixon The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J. Biol. Chem. 273 1998 13375 13378
11. F.B. Furnari, H. Lin, H.S. Huang, and W.K. Cavenee Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain Proc. Natl Acad. Sci. USA 94 1997 12479 12484
12. S.Y. Han, H. Kato, S. Kato, T. Suzuki, H. Shibata, and S. Ishii Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay Cancer Res. 60 2000 3147 3151
13. C.M. Fenoglio-Preiser, J. Wang, G.N. Stemmermann, and A. Noffsinger TP53 and gastric carcinoma: a review Hum. Mutat. 21 2003 258 270
14. M.B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig Participation of p53 protein in the cellular response to DNA damage Cancer Res. 51 1991 6304 6311
15. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
16. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
17. V. Stambolic, D. MacPherson, D. Sas, Y. Lin, B. Snow, and Y. Jang Regulation of PTEN transcription by p53 Mol. Cell 8 2001 317 325
18. J.H. Mao, D. Wu, J. Perez-Losada, H. Nagase, R. DelRosario, and A. Balmain Genetic interactions between Pten and p53 in radiation-induced lymphoma development Oncogene 22 2003 8379 8385
19. Y. Maehara, Y. Kakeji, S. Oda, H. Baba, and K. Sugimachi Tumor growth patterns and biological characteristics of early gastric carcinoma Oncology 61 2001 102 112
20. S. Oda, E. Oki, Y. Maehara, and K. Sugimachi Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis Nucl. Acids Res. 25 1997 3415 3420
21. Y. Maehara, S. Oda, and K. Sugimachi The instability within: problems in current analyses of microsatellite instability Mutat. Res. 461 2001 249 263
22. Y. Gomyo, M. Osaki, N. Kaibara, and H. Ito Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP Int. J. Cancer 66 1996 594 599
23. K.R. Cho, and B. Vogelstein Suppressor gene alterations in the colorectal adenoma-carcinoma sequence J. Cell Biochem. Suppl. 16G 1992 137 141
24. B. Tang, E.P. Bottinger, S.B. Jakowlew, K.M. Bagnall, J. Mariano, and M.R. Anver Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency Nat. Med. 4 1998 802 807
25. M.L. Fero, E. Randel, K.E. Gurley, J.M. Roberts, and C.J. Kemp The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature 396 1998 177 180